REALLY™, we love challenges at claretbio

Input DNA integrity and amount can affect the quality of the NGS data that you can procure from your clinical samples. FFPE DNA, cfDNA, ancient DNA while readily available often suffer from pre-analytical artifacts. Up to 10-30% of biological samples are precluded from NGS analytical workflows based on DNA quality - you are challenged from the start!

At ClaretBio, our mission is to get the “Best data from the Worst Samples”. Our flagship method SRSLY® captures high quality data from the most challenging inputs. Meet us at ABRF 2024 at BOOTH#209 or attend our talk, to learn how.